HIV-1 genetic diversity a challenge for AIDS vaccine development: a retrospective bibliometric analysis

Hum Vaccin Immunother. 2022 Dec 31;18(1):2014733. doi: 10.1080/21645515.2021.2014733. Epub 2022 Jan 11.

Abstract

Background: Despite recent advances in human immunodeficiency virus-1 (HIV-1) prevention, a fast, safe, and effective vaccine will probably be necessary to end the HIV/AIDS pandemic. This study was conducted to evaluate global research trends and map the key bibliometric indices in HIV-1 genetic diversity from 1998 to 2021.

Methods: A comprehensive online search was conducted in the Web of Science Core Collection database to retrieve published literature on HIV-1 genetic diversity. Key bibliometric indicators were calculated and evaluated using HistCiteTM, Bibliometrix: An R-tool, and VOSviewer software for windows.

Results: A total of 2,060 documents written by 9,201 authors and published in 250 journals were included in the final analysis. Year 2012 was the most productive year with 121 (5.87%) publications. The most prolific author was Shao Yiming (n = 74, 3.59%) from Chinese Center for Disease Control and Prevention. The United States of America was the highly contributing and influential country (n = 681, 33.05%). AIDS Research and Human Retroviruses was the most productive journal (n = 562, 27.2%). Network visualization shows that HIV-1 was the most widely used author keyword.

Conclusion: This study provides global research trends and detailed information on HIV-1 genetic diversity. The amount of scientific literature on HIV-1 genetic diversity research has rapidly increased in the last two decades. The maximum number of articles on HIV-1 genetic diversity was published in developed countries; therefore, a scientific research collaboration among researchers and institutes in low-income countries should be promoted and supported.

Keywords: HIV-1; Web of Science Core Collection; bibliometric analysis; genetic diversity; vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Vaccines* / genetics
  • Bibliometrics
  • Genetic Variation
  • HIV-1* / genetics
  • Humans
  • Retrospective Studies
  • United States

Substances

  • AIDS Vaccines

Grants and funding

This work was supported by the National Science and Technology Major Project of China [grant number: 2018ZX10731-101], Science Priority [Grant 2019SKLID602] from the State Key Laboratory of Infections Disease Prevention and Control, National Natural Science Foundation International/Inter-Organization Cooperation and Exchange Study-NSFC-VR Project (China and Switzerland) [grant number 81861138011].